Uzun, H.; Bozarslan, G.; Dumur, S.; Misirlioglu, N.F.; Elgormus, M.N.; Duvarcı, C.; Gelisgen, R.; Karaaltin, A.B.; Yilmaz, Y.Z.
Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia. Diagnostics 2026, 16, 206.
https://doi.org/10.3390/diagnostics16020206
AMA Style
Uzun H, Bozarslan G, Dumur S, Misirlioglu NF, Elgormus MN, Duvarcı C, Gelisgen R, Karaaltin AB, Yilmaz YZ.
Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia. Diagnostics. 2026; 16(2):206.
https://doi.org/10.3390/diagnostics16020206
Chicago/Turabian Style
Uzun, Hafize, Guven Bozarslan, Seyma Dumur, Naile Fevziye Misirlioglu, Mehmet Nuri Elgormus, Canan Duvarcı, Remise Gelisgen, Aysegul Batioglu Karaaltin, and Yetkin Zeki Yilmaz.
2026. "Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia" Diagnostics 16, no. 2: 206.
https://doi.org/10.3390/diagnostics16020206
APA Style
Uzun, H., Bozarslan, G., Dumur, S., Misirlioglu, N. F., Elgormus, M. N., Duvarcı, C., Gelisgen, R., Karaaltin, A. B., & Yilmaz, Y. Z.
(2026). Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia. Diagnostics, 16(2), 206.
https://doi.org/10.3390/diagnostics16020206
